Rain Oncology Inc. Comprehensive Income
Rain Oncology Inc. reported Comprehensive Income of -$7.00 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Income Statement
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2023-11-09
- Rain Oncology Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-09-30 was -$7.00M.
- Rain Oncology Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-06-30 was -$22.12M.
- Rain Oncology Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-03-31 was -$20.36M.
- Rain Oncology Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-12-31 was -$22.54M.
- Rain Oncology Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$75.80M.
- Rain Oncology Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$51.48M.
- Rain Oncology Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$21.08M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$7.00M 10-Q · filed 2023-11-09 | -$29.11M derived: sum of 2 quarters · filed 2023-11-09 | -$49.48M 10-Q · filed 2023-11-09 | -$72.02M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | -$22.12M 10-Q · filed 2023-08-10 | -$42.48M 10-Q · filed 2023-08-10 | -$65.02M derived: sum of 3 quarters · filed 2023-08-10 | -$82.99M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-03-31 | -$20.36M 10-Q · filed 2023-05-11 | -$42.91M derived: sum of 2 quarters · filed 2023-05-11 | -$60.88M derived: sum of 3 quarters · filed 2023-11-09 | -$78.47M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-12-31 | -$22.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$40.51M derived: sum of 2 quarters · filed 2023-11-09 | -$58.11M derived: sum of 3 quarters · filed 2023-11-09 | -$75.80M 10-K · filed 2023-03-09 |
| 2022-09-30 | -$17.97M 10-Q · filed 2023-11-09 | -$35.56M derived: sum of 2 quarters · filed 2023-11-09 | -$53.26M 10-Q · filed 2023-11-09 | -$71.34M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$17.59M 10-Q · filed 2023-08-10 | -$35.29M 10-Q · filed 2023-08-10 | -$53.37M derived: sum of 3 quarters · filed 2023-08-10 | -$71.79M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$17.69M 10-Q · filed 2023-05-11 | -$35.77M derived: sum of 2 quarters · filed 2023-05-11 | -$54.19M derived: sum of 3 quarters · filed 2023-05-11 | -$62.38M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$18.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$36.50M derived: sum of 2 quarters · filed 2023-03-09 | -$44.68M derived: sum of 3 quarters · filed 2023-03-09 | -$51.48M 10-K · filed 2023-03-09 |
| 2021-09-30 | -$18.42M 10-Q · filed 2022-11-10 | -$26.60M derived: sum of 2 quarters · filed 2022-11-10 | -$33.40M 10-Q · filed 2022-11-10 | -$38.85M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$8.18M 10-Q · filed 2022-08-04 | -$14.98M 10-Q · filed 2022-08-04 | -$20.43M derived: sum of 3 quarters · filed 2022-08-04 | -$30.87M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$6.80M 10-Q · filed 2022-05-04 | -$12.24M derived: sum of 2 quarters · filed 2022-05-04 | -$22.69M derived: sum of 3 quarters · filed 2022-05-04 | |
| 2020-12-31 | -$5.44M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$15.89M derived: sum of 2 quarters · filed 2022-03-03 | -$21.08M 10-K · filed 2022-03-03 | |
| 2020-09-30 | -$10.45M 10-Q · filed 2021-11-10 | -$15.64M 10-Q · filed 2021-11-10 |